BECLOMETASONE TEVA 400 micrograms/1 ml, suspension for inhalation by nebulizer in a single-dose container 20 single-dose containers of 1 ml
Active ingredients: DIPROPIONATE DE BÉCLOMÉTASONE
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for inhalation by nebulizer20 single-dose containers of 1 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BECLOMETASONE TEVA 400 microgrammes/1 ml, suspension pour inhalation par nébuliseur en récipient unidose
- Pharmaceutical form
- suspension pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 20 récipient(s) unidose(s) polyéthylène de 1 ml suremballée(s)/surpochée(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Feb 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63111747CIP73006702CIP133400930067024Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DIPROPIONATE DE BÉCLOMÉTASONEsuspension | 400 microgrammes · un récipient unidose de 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BECLOMETASONE (DIPROPIONATE DE) 400 microgrammes/1 mL - BECLOSPIN 400 microgrammes/1 ml, suspension pour inhalation par nébuliseur